Core Scientific stock falls as operational setbacks at Texas data center weigh on sentiment

Traders Union
All News
Financial News
Core Scientific drops 3.15% today

Highlights

CoreWeave cut its full-year 2025 guidance due to construction delays at the 260MW Denton, Texas facility, directly impacting both Core Scientific and project revenue expectations.
The guidance revision connects Core Scientific (Nasdaq: CORZ) to operational and financial outcomes of a major U.S. data center expansion, with associated selling pressure in shares.
CORZ trades at $17.51, just above key support at $17.38, with momentum mixed but technicals indicate an 80% probability of a move within the $16.90–$18.50 range over five days.

Revenue risks heightened as data center delays drive guidance cut

In late 2025, CoreWeave was forced to cut its full-year guidance due to construction delays at its 260MW facility in Denton, Texas, a project managed in partnership with Core Scientific (Nasdaq: CORZ). This update connects Core Scientific to the operational and financial outcomes of a major U.S. data center expansion. The guidance revision reflects the impact of project delays on anticipated revenue for both partners, though price action has remained under broader selling pressure.

Upward momentum diverges from intraday weakness as signals mix

Momentum signals are mixed: the MACD shows a buy signal while the ADX is neutral, suggesting limited trend strength. The RSI sits at 53.27 (neutral-bullish), while the Stochastic RSI and Bull/Bear Power both show overbought conditions, signaling buyers still dominate, though the Commodity Channel Index is neutral. The Awesome Oscillator remains neutral and does not support a distinct trend in the current setup. The price declined 3.15% during the session, opening with only a small gap from the previous close, and now trades at the lower end of today’s range ($17.50 – $18.09). Intraday volatility is moderate, and the tone is under pressure after the open, with a clear divergence between upward daily momentum signals and intraday selling.

Sideways outlook prevails as bullish odds outweigh downside risk

For the next five trading days, the expected price range is $16.90 to $18.50, reflecting typical volatility relative to current levels. The probability of a price increase is high (80%), with a much lower likelihood of a downward move, based on supportive weekly signals from the MACD, RSI, and Moving Averages. The baseline scenario sees the price moving sideways within this corridor. In the bullish scenario, a breakout above $18.10 could open the way toward the upper range, while a bearish scenario would follow a break below immediate support at $17.38, risking a dip toward the $17 level.

Viktoras Karapetjanc, analyst at Traders Union, sees Core Scientific maintaining a robust medium- and long-term technical profile despite short-term headwinds. He notes that the Denton project delay has dampened sentiment but has not altered supportive weekly signals or the bullish foundation. The analyst believes moderate volatility and strong macro fundamentals create favorable conditions for a move toward the upper price range. Karapetjanc expects sideways movement with a positive bias in the coming days. "The technical and macro setup points to high odds of further gains as long as $17.38 holds and news flow remains constructive."

Last time, analysts noted that Core Scientific Inc. is trading just below its short-term moving average and above its medium- and long-term averages, reflecting ongoing short-term selling pressure but continued intermediate support. Mixed momentum indicators—including a neutral MACD, weak ADX, and mildly bearish oscillators—suggest the potential for near-term consolidation unless key support or resistance levels are breached.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.